... 57:1215-1220.2. Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW: The Roles of Dopamine and Noradrenaline in the Pathophysiology andTreatment of Attention- Deficit/ Hyperactivity Disorder. Biol Psychiatry ... 11:176http://www.biomedcentral.com/1471-244X/11/176Page 4 of 8 RESEARCH ARTICLE Open AccessComparative efficacy and acceptability of methylphenidate and atomoxetine in treatment ofattentiondeficithyperactivitydisorder in children and adolescents: ... Hanwella et al.: Comparative efficacy and acceptability of methylphenidate and atomoxetine intreatment of attentiondeficithyperactivitydisorderin children and adolescents: ameta-analysis. BMC...
... withAttention -Deficit/ HyperactivityDisorderin theUnited Kingdom. Value Health 2008, 11(3):376-388.28. Brown TE: Emerging Understanding of Attention- Deficit Disorders and Comorbidities in Attention- Deficit Disorders and ... Modi N, Linde-mulder E, Wigal S: Development of a new once-a-day formula-tion of methylphenidate for the treatmentof attention- deficit/ hyperactivity disorder: proof -of- concept and proof -of- product ... systematicre-view and economic model of the effectiveness and cost-effec-tivenessof methylphenidate, dexamfetamine and atomoxetine for the treatmentof attentiondeficit hyperac-tivity disorderin children andadolescents....
... calculatedresting on very conservative assumptions (cf. Tables 4 and 5) regarding diagnosis andtreatment prevalencerates, absence of any further increase intreatment inten-sity, a disappointing clinical ... potential clinical uses and mechanisms of action. Journal ofClinical Psychi-atry 2006, 67(4):554-566.56. Turner D: A review of the use of modafinil for attention- defi-cit hyperactivity disorder. ... Cost-Effec-tiveness of Clinically Proven Treatment Strategies for Attention- Deficit/ HyperactivityDisorder (ADHD) in theUnited States, Germany, The Netherlands, Sweden, and United Kingdom. Value in Health...
... impulsivity. As Klimkeit and Bradshaw point out in Chapter 21 of this book, in certain other historical settings, 22 HANDBOOK OFATTENTIONDEFICITHYPERACTIVITY DISORDER 1988) and it is unclear as ... understanding of the diagnosis and classifi cation of ADHD in childhood. In addition, we will describe the rating scales used in aiding diagnosis. We begin by tracing the evolution of our understanding ... 123–9. THE HISTORY OFATTENTIONDEFICITHYPERACTIVITYDISORDER 9Coinciding with the work of Douglas, researchers in Northern Europe became more interested in the concept ofhyperactivity as a...
... Landgraf JM, Rich M, Rappaport L: Measuring quality of life in chil-dren with attention- deficit/ hyperactivitydisorderand theirfamilies: Development and evaluation of a new tool. Archives of ... BueschingDP: Quality of life of adolescent males with attention- deficit hyperactivity disorder. Journal ofAttention Disorders 2004,7:163-173.21. Landgraf JM, Abetz LN: Functional status and ... quality of life andtreatment satisfaction and prefer-ence in a community assessment study of extended-releasemixed amphetamine salts for children with attention- deficit/ hyperactivity disorder. ...
... with learning Clinical use of a modified release methylphenidate in the treatmentof childhood attentiondeficithyperactivitydisorder Inyang Takon* QE II Hospital, East and North Hertfordshire ... increasing concerns regarding his behaviour at home and at school. The assessments consisted of a diagnostic interview by clinicians and a screening of the information received from home and the ... in the UK for the management of ADHD in school-age children and young people, and are effective in controlling ADHD symptoms [9]. The guidelines produced by the UK National Institute of Clinical...
... of Pediatrics Committee on Quality Improve-ment, Subcommittee on Attention- Deficit/ Hyperactivity Disorder: Clinical practice guideline: Diagnosis and evaluation of thechild with attention- deficit/ hyperactivity ... Amulti-centre, randomized, open-label study of atomoxetinecompared with standard current therapy in UK children and adolescents with attention- deficit/ hyperactivity disorder (ADHD). Curr Med Res Opin 2007, ... moderate in intensity, and the most commonlyreported AEs included headache, decreased appetite, insomnia, and abdominal pain. Seven subjects discontinued the study dueto intolerable AEs (n = 3) and...
... adults& apos; requests21 Has trouble concentrating in class22 has difficulty waiting in lines or awaiting turn in games or group situations23 Leaves seat in classroom or other situation in ... hour of time playingvideo games. It would be interesting to examine the lattercohort in more detail to determine if there is a linear rela-tionship between time spent playing video games and ADHD ... era of communication and socialdevelopment. Further advances in technology led to thecreation of the telephone, radio, and television. Recently,the Internet has become the pinnacle of interchange...
... into non-aggressive subtypes. There were significant improvements inclinical symptoms of hyperactivityand inattention, and impulsivity performance in CPT during the 6-month treatment. The clinical hyperactive ... categorized into3 subtypes, including inattentive type, hyperactive-impul-sive type, and combined t ype, according to the predomi-nant clinical manifestations of inattention, hyperactivity, and impulsivity. ... deficit hyperactivitydisorder (ADHD) clinical symptoms and neurocognitive function in a realistic clinical setting, and thedifferences in ADHD symptom improvement using different classifications of...
... that participates in the signal transduction path-ways of insulin and insulin-like growth factors. This protein is highly expressed in the left cortex and seems to be involved in neuronal proliferation, ... be involved in ADHD etiology, with BAIAP2 acting specifically in cases of persistent ADHD.BAIAP2 is located at 17q25 and encodes the 53 kDa insulin receptor tyrosine kinase substrate protein ... mara.hutz@ufrgs.brADHD, attention- deficit/ hyperactivity disorder; BAIAP2, brain-specific angiogenesis inhibitor 1-associated protein 2 gene; BDKRB2, brady-kinin receptor B2 gene; DAT1, dopamine transporter...
... Anadvantage of using QTDT in association analyses usingtwin data is that all families remain informative regard-less of twin class. QTDT tests for association in a var-iance components framework and ... RY: A meta-analysis of association studies between the 10-repeat allele of a VNTRpolymorphism in the 3’-UTR of dopamine transporter gene and attentiondeficithyperactivity disorder. Am J Med ... R, Franke B,Gill M, Ebstein R, et al: The analysis of 51 genes in DSM-IV combinedtype attentiondeficithyperactivity disorder: association signals in DRD4,DAT1 and 16 other genes. Mol Psychiatry...
... affecting 2-4% ofadults [1]. The coresymptoms of ADHD are inattention, hyperactivity and impulsivity. Further, deficits in executive functioning arecommonplace, such as planning, organising, ... disorder (attention- deficit/ hyperactivity disorder without hyperactivity) : a neurobiologically and behaviourallydistinct disorder from attention- deficit/ hyperactivitydisorder (with hyperactivity) . ... and functionalimpairment in a clinically referred sample ofadults with attention- deficit/ hyperactivitydisorder (ADHD). Eur Arch Psychiatry Clin Neurosci2007, 257(7):371-377.5. Eme RF: Attention- deficit/ hyperactivity...
... Cacace AT, McFarland DJ: Delineating Auditory Processing Disorder (APD) and AttentionDeficitHyperactivityDisorder (ADHD): A Conceptual,Theoretical, and Practical Framework. In An introduction ... Methylphenidate and if-thenplans are comparable in modulating the P300 and increasing responseinhibition in children with ADHD. ADHD AttentionDeficitand Hyperactivity Disorders 2010.61. Durston S, Tottenham ... RJ,Camfferman G, van Engeland H: Event-related brain potentials in childrenwith attention- deficitandhyperactivity disorder: effects of stimulusdeviancy and task relevance in the visual and auditory modality....